HomeGRCE • NASDAQ
add
Grace Therapeutics, Inc
Previous close
$3.53
Day range
$3.48 - $3.70
Year range
$1.75 - $3.94
Market cap
55.86M USD
Avg Volume
105.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.45M | -33.88% |
Net income | -2.32M | 44.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.45M | 33.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.67M | 68.90% |
Total assets | 68.49M | 11.86% |
Total liabilities | 3.60M | -60.42% |
Total equity | 64.89M | — |
Shares outstanding | 15.47M | — |
Price to book | 0.84 | — |
Return on assets | -9.07% | — |
Return on capital | -9.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.32M | 44.28% |
Cash from operations | -2.23M | 45.81% |
Cash from investing | — | — |
Cash from financing | 4.04M | — |
Net change in cash | 1.81M | 144.15% |
Free cash flow | -1.59M | 44.11% |
About
Founded
2002
Website
Employees
6
